Jennifer Morton's practice extends to all aspects of trademark clearance, prosecution and opposition proceedings as well as licensing, assignment and security interest issues. Jennifer represents Canadian and multinational clients in all industry segments with specialized expertise in Canadian pharmaceutical clearance (including predictions for regulatory approval of pharmaceutical brands), consumer products, financial services, computer software, social networking, sporting goods and apparel, etc. With 28 years of experience in Canadian trademark clearance, prosecution, and opposition, Jennifer is able to provide expert advice to clients including the implementation of and strategies for dealing with Canada's new Trademarks Act and Regulations, its adherence to the Madrid Protocol, and the unique aspects of brand protection in Canada. Jennifer also specialises in foreign prosecution matters, including the strategic management of international prosecution portfolios.
A registered trade mark agent since 1990, Jennifer became a partner in 1996. She is an active member of the International Trademark Association (INTA) and is the Chair the Trademarks Office Practices Committee for Canada and a member of the North American Global Advisory Council of INTA, the Pharmaceutical Trade Mark Group (PTMG), the Association of European Trade Mark Owners, the American Bar Association, and the International Association for the Protection of Industrial Property. A member of the Intellectual Property Institute of Canada ("IPIC") Jennifer currently sits on the Joint Liaison Committee of IPIC which works together with Canadian Trademarks Office Examiners and its executive to develop practice policies and enhance trademark registration processes in Canada for brand owners.
Jennifer is a frequent speaker on trade mark issues and pharmaceutical brand clearance considerations in light of Health Canada's revised regulatory guidance document on Look-alike/Sound-alike brand names.